Unexpected Erythroid and Cytogenetic Responses After Discontinuation of a Short Course of Lenalidomide As a Result of Severe Skin Rash in a Patient With 5q Syndrome

被引：6

作者：

Breccia, Massimo ^{[1
]}

Cannella, Laura ^{[1
]}

Latagliata, Roberto ^{[1
]}

Loglisci, Giuseppina ^{[1
]}

Salaroli, Adriano ^{[1
]}

Santopietro, Michelina ^{[1
]}

Oliva, Esther N. ^{[2
]}

Alimena, Giuliana ^{[1
]}

机构：

[1] Univ Roma La Sapienza, Rome, Italy

[2] Azienda Osped Bianchi Melacrino Morelli, Reggio Di Calabria, Italy

来源：

JOURNAL OF CLINICAL ONCOLOGY | 2011年 / 29卷 / 14期

关键词：

MYELODYSPLASTIC SYNDROMES; MDS;

D O I：

10.1200/JCO.2010.33.5083

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

[No abstract available]

引用

页码：E402 / E403

页数：2

共 5 条

[1]

Galili Naomi, 2006, Expert Opin Investig Drugs, V15, P805, DOI 10.1517/13543784.15.7.805

[2] Lenalidomide in the context of complex karyotype or interrupted treatment:: case reviews of del(5q) MDS patients with unexpected responses [J].

Giagounidis, Aristoteles A. N. ;

Haase, Sabine ;

Heinsch, Michael ;

Goehring, Gudrun ;

Schlegelberger, Brigitte ;

Aul, Carlo .

ANNALS OF HEMATOLOGY, 2007, 86 (02) :133-137

[3] Efficacy of lenalidomide in myelodysplastic syndromes [J].

List, A ;

Kurtin, S ;

Roe, DJ ;

Buresh, A ;

Mahadevan, D ;

Fuchs, D ;

Rimsza, L ;

Heaton, R ;

Knight, R ;

Zeldis, JB .

NEW ENGLAND JOURNAL OF MEDICINE, 2005, 352 (06) :549-557

[4] Emerging data on IMiDs in the treatment of myelodysplastic syndromes (MDS) [J].

List, AF .

SEMINARS IN ONCOLOGY, 2005, 32 (04) :S31-S35

[5] Lenalidomide in the myelodysplastic syndrome with chromosome 5q deletion [J].

List, Alan ;

Dewald, Gordon ;

Bennett, John ;

Giagounidis, Aristotle ;

Raza, Azra ;

Feldman, Eric ;

Powell, Bayard ;

Greenberg, Peter ;

Thomas, Deborah ;

Stone, Richard ;

Reeder, Craig ;

Wride, Kenton ;

Patin, John ;

Schmidt, Michele ;

Zeldis, Jerome ;

Knight, Robert .

NEW ENGLAND JOURNAL OF MEDICINE, 2006, 355 (14) :1456-1465

← 1 →